Cinaciguat
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Cinaciguat, covering 2015-10-08 to 2015-10-08. Get the full timeline:
Most recent: Clinical Trial Update: A Phase IIb Study to Investigate the Efficacy and Tolerability of Cinaciguat (150 µg/h, 100 µg/h, 50 µg/h) Given Intravenously to Subjects With Acute Decompensated Chronic Congestive Heart Failure (ADHF) [Phase 2]